The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Heron Therapeutics Inc shares valued at $27,250 were purchased by Forbes William P on Nov 17 ’23. At $1.09 per share, Forbes William P acquired 25,000 shares. The insider’s holdings grew to 79,000 shares worth approximately $0.22 million following the completion of this transaction.
Also, Collard Craig A purchased 150,000 shares, netting a total of over 137,970 in proceeds. Following the buying of shares at $0.92 each, the insider now holds 186,496 shares.
Before that, Duarte Ira had added 85,000 shares to its account. In a trade valued at $75,599, the EVP, Chief Financial Officer bought Heron Therapeutics Inc shares for $0.89 each. Upon closing the transaction, the insider’s holdings increased to 85,000 shares, worth approximately $0.23 million.
As published in a research note from Needham on March 13, 2024, Heron Therapeutics Inc [HRTX] has been retained to a Buy and the price target has been revised to $5. Analysts at Guggenheim started covering the stock with ‘”a Buy”‘ outlook in a report released in late May. As of February 20, 2020, Needham has reiterated its “Buy” rating for HRTX. Earlier on January 16, 2019, Needham resumed its rating. Their recommendation was “a Buy” for HRTX stock.
Analyzing HRTX Stock Performance
During the last five days, there has been a surge of approximately 6.23%. Over the course of the year, Heron Therapeutics Inc shares have jumped approximately 60.59%. Shares of the company reached a 52-week high of $3.22 on 03/13/24 and a 52-week low of $1.66 on 01/02/24. A 50-day SMA is recorded $2.67, while a 200-day SMA reached $1.70. Nevertheless, trading volume fell to 1.59 million shares from 1.03 million shares the previous day.
Support And Resistance Levels for Heron Therapeutics Inc (HRTX)
According to the 24-hour chart, there is a support level at 2.65, which, if violated, would cause prices to drop to 2.58. In the upper region, resistance lies at 2.82. The next price resistance is at 2.91. RSI (Relative Strength Index) is 50.34 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.00, which suggests the price will decrease in the coming days. Percent R is at 67.14%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
Is Heron Therapeutics Inc subject to short interest?
Stocks of Heron Therapeutics Inc saw a sharp rise in short interest on Mar 28, 2024 jumping by 1.02 million shares to 25.55 million. Data from Yahoo Finance shows that the short interest on Feb 29, 2024 was 24.53 million shares. A jump of 3.99% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 9.17 of the overall float, the days-to-cover ratio (short ratio) jumped to 9.17.
